News by Tag: Fibrates Market
US Cholesterol Lowering Agents Market on the Edge of a Patent Cliff
August 5, 2011
A new report from IMARC Group expects that as a result of an avalanche of patent expiries and a thin pipeline, sales worth US$ 8.7 Billion will be eroded from the US cholesterol lowering agent market.
August 5, 2011
A new report from IMARC Group expects that as a result of an avalanche of patent expiries and a thin pipeline, sales worth US$ 8.7 Billion will be eroded from the US cholesterol lowering agent market.